ABEV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ambev SA (ABEV) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is showing signs of weakness in its technical indicators, financial performance, and trading sentiment. While analysts have slightly raised the price target, the lack of significant positive catalysts and the recent financial underperformance suggest that waiting for a better entry point or stronger signals would be prudent.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is at 29.265, which is close to oversold territory but not yet signaling a reversal. Moving averages are converging, suggesting indecision. The stock is trading below the pivot level of 3.07, with key support at 2.932 and resistance at 3.208. Overall, the technical indicators point to a bearish trend.
Barclays raised the price target to $3 from $2.50, citing profitability-led earnings and cash flow growth potential by 2026.
Hedge funds are selling heavily, with a 9796.69% increase in selling activity last quarter. The company's financials for Q4 2025 showed declines in revenue (-8.24% YoY), net income (-10.94% YoY), EPS (-9.68% YoY), and gross margin (-1.96% YoY). No significant insider or congress trading activity was reported. No recent news or event-driven catalysts.
Ambev's Q4 2025 financials indicate a decline across key metrics: revenue dropped to 24.8 billion (-8.24% YoY), net income fell to 4.35 billion (-10.94% YoY), EPS decreased to 0.28 (-9.68% YoY), and gross margin declined to 52.63% (-1.96% YoY). These results highlight a challenging financial environment for the company.
Barclays raised the price target to $3 from $2.50 while maintaining an Equal Weight rating. This suggests cautious optimism but not a strong buy recommendation.
